Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 09, 2022
Polyplus has announced the completed acquisition of Xpress Biologics, a Belgian contract development and manufacturing organization (CDMO) specialized in the production of plasmid DNA and protein using microbial expression systems.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
Monday, September 09, 2019
Polpharma Biologics has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar.
read more
Wednesday, March 18, 2020
The FDA is issuing this guidance to provide a policy to help accelerate the availability of novel coronavirus tests developed by laboratories and commercial manufacturers during the public health emergency.
read more
Thursday, September 19, 2019
PMRS has filed a petition asking the U.S. Court of Appeals for the District of Columbia Circuit to overturn the FDA's refusal to approve a new opioid capsule intended to deter abuse.
read more
Monday, February 09, 2015
Platinum Press, Inc. (PPI) is now a fully certified print packaging supplier for all Walgreens pharmacies. To earn the quality assurance seal, PPI underwent a stringent program administered by Graphic Measures International (GMI), an organization ...
read more
Friday, December 22, 2017
PixarBio developers of NeuroRelease NR14 announce an agreement between PSI, a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14.
read more
Piramal Pharma announced the company will be partnering with Epirium Bio on a manufacturing relationship for new orphan drugs.
read more
Tuesday, December 21, 2021
Piramal Pharma Limited (PPL) announced an investment of INR101.77cr in Yapan Bio Pvt Ltd (“Yapan”) of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (...
read more
PPL's, Piramal Pharma Solutions, announced the Company has entered into a Master Services Agreement.
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
Tuesday, January 28, 2020
Piramal Enterprises’ Pharma Solutions business announced plans to expand its Aurora facility in Canada with the addition of a new wing dedicated to manufacturing APIs.
read more
Tuesday, November 20, 2018
Piramal Pharma Solutions announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore, Chennai, India.
read more
Piramal Pharma Limited's Pharma Solutions announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).
read more